Literature DB >> 6712540

Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans.

D R Illingworth, W S Harris, W E Connor.   

Abstract

Diets rich in omega-3 fatty acids derived from fish oils lower the plasma concentrations of low density lipoproteins (LDL) and very low density lipoproteins in humans. The present study was designed to examine the mechanism(s) by which diets enriched in omega-3 fatty acids reduce plasma LDL cholesterol levels in normal subjects. Seven healthy volunteers with normal plasma lipid levels consumed two metabolically controlled diets for a period of 4 weeks each. The control diet contained predominantly saturated and monounsaturated fatty acids, whereas the fish-oil diet contained 24 gm of omega-3 fatty acids per day. The total fat and cholesterol content of the two diets were similar for each subject. Total and LDL cholesterol levels decreased from 162 +/- 26 mg/dl and 103 +/- 27 mg/dl on the control diet to 124 +/- 26 mg/dl and 82 +/- 27 mg/dl on the omega-3-rich diet. Triglyceride levels fell from 91 +/- 34 mg/dl to 52 +/- 19 mg/dl. Kinetic studies of 125I-LDL metabolism disclosed a significantly lower rate of synthesis of LDL apoprotein B on the omega-3-rich diet (9.5 +/- 1.3 mg/kg/day) as compared to the control diet (13.6 +/- 3.7 mg/kg/day; p less than 0.05). In contrast, the fractional catabolic rate was similar on both diets. We conclude that dietary omega-3 fatty acids lower plasma LDL levels in normal human subjects by reducing the rate of synthesis of apoprotein B.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712540     DOI: 10.1161/01.atv.4.3.270

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  28 in total

1.  Effects of omega-3 fatty acids on vascular smooth muscle cells: reduction in arachidonic acid incorporation into inositol phospholipids.

Authors:  N R Yerram; A A Spector
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

Review 2.  Fatty acid composition of the diet: impact on serum lipids and atherosclerosis.

Authors:  N Zöllner; F Tatò
Journal:  Clin Investig       Date:  1992-11

3.  Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.

Authors:  H M Vidgren; J J Agren; U Schwab; T Rissanen; O Hänninen; M I Uusitupa
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

4.  Benefits of omega-3 Fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome.

Authors:  Elahe Mohammadi; Maryam Rafraf
Journal:  Health Promot Perspect       Date:  2012-12-28

5.  New findings in the fatty acid composition of individual platelet phospholipids in man after dietary fish oil supplementation.

Authors:  T A Mori; J P Codde; R Vandongen; L J Beilin
Journal:  Lipids       Date:  1987-10       Impact factor: 1.880

Review 6.  Fish and coronary artery disease.

Authors:  T A Sanders
Journal:  Br Heart J       Date:  1987-03

7.  Regulation of hepatic very-low-density lipoprotein secretion in rats fed on a diet high in unsaturated fat.

Authors:  G F Gibbons; C R Pullinger
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

8.  Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats.

Authors:  M J Smit; A M Temmerman; H Wolters; F Kuipers; A C Beynen; R J Vonk
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Serum lipids in spontaneously hypertensive rats and Sprague-Dawley rats fed menhaden oil.

Authors:  T R Kingsley; D L Snyder
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

10.  A diet containing n-3 and n-6 fatty acids favorably alters the renal phospholipids, eicosanoid synthesis and plasma lipids in nephrotic rats.

Authors:  U O Barcelli; D C Beach; B Thompson; M Weiss; V E Pollak
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.